Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.

Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q38635603
Genetic alterations in hepatocellular carcinoma: An updateDifferential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells.Sorafenib in breast cancer treatment: A systematic review and overview of clinical trialsTRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.Recombinant adeno-associated virus expressing a p53-derived apoptotic peptide (37AA) inhibits HCC cells growth in vitro and in vivo.C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.Systematic Analysis of Quantitative Logic Model Ensembles Predicts Drug Combination Effects on Cell Signaling NetworksIncreased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment.Downregulation of BRAF-activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells.Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation.Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option.Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival.Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signalingMicroRNA199a-Based Post-transcriptional Detargeting of Gene Vectors for Hepatocellular CarcinomaDesign, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors
P2860

Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q38635603
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.
@en
type
label
Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.
@en
prefLabel
Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932